The guideline recommends testing tissue transglutaminase IgA (tTGA) and total serum IgA for suspected celiac disease and testing hemoglobin, leukocytes and ESR for suspected inflammatory bowel disease (IBD). Here, CD79A is linked to irritable bowel syndrome.